Latest Funding News

Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.

Arafura Rare Earths has locked in a A$200 million convertible note investment from the National Reconstruction Fund Corporation, marking a pivotal step toward developing Australia's first ore-to-oxide rare earths processing operation at Nolans.

Ingenia Communities Group has raised its FY25 EBIT and EPS guidance following a robust first half, driven by operational efficiencies and a revitalised development pipeline.

HITIQ Limited has received $1.6 million from the R&D Tax Incentive Scheme, using most of it to repay its RDTI Facility with Keystone Capital Partners, signaling a strategic move to streamline its R&D funding.

Nex Metals Explorations has repriced and partially completed its capital raise, securing $1.06 million at a reduced share price to fund development and exploration activities.

MRG Metals has achieved a major milestone with the official approval and signing of the Corridor Central Heavy Mineral Sands mining licence in Mozambique, unlocking development potential for its world-class Koko Massava deposit.

Arrow Minerals is fast-tracking a Scoping Study for a Direct Shipping Ore operation at its Niagara Bauxite Project in Guinea, leveraging strong drilling results and strategic infrastructure access to capitalise on record bauxite prices.

ADX Energy has suspended testing at its Welchau-1 gas well in Upper Austria following a landmark Austrian Constitutional Court ruling that repealed a legal provision preventing environmental objections from halting operations. This development introduces regulatory uncertainty amid ongoing evaluation of the well’s potential.

Centrex Limited has initiated a $10.4 million entitlement offer to fund essential plant upgrades and strengthen working capital, following a strategic logistics debt restructuring. The raise is pivotal for advancing the Ardmore phosphate project and maintaining financial viability.

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

Magnetic Resources NL reported a $4.39 million net cash outflow from operations in Q4 2024 but strengthened its balance sheet with a $9.41 million financing inflow, ending the quarter with $11.6 million in cash.

The Australian Takeovers Panel has declared unacceptable circumstances in Alara Resources Limited's recent rights issue, citing inadequate disclosure and potential control issues involving Al Tasnim Infrastructure LLC. The company faces a costs order and must reassess its fundraising approach.